ArticleScientific reports2019

Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats.

Edward J R Fletcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.